How Roche Reduced Unnecessary Protocol Amendments to Impact Timeline and Cost

PharmaTalkRadio · 2025-10-21

About this podcast:
Liz Thompson, Global Development Leader, Senior Clinical Development Scientist at Roche, presented how the organization had delivered a single, cohesive protocol amendment categorization process to reduce the number of amendments and create a continuous improvement strategy, all to speed up timelines and reduce costs. This presentation comes from the September 2025 DPHARM: Disruptive Innovations to Modernize Clinical Research program.

More specifically, Ms Thompson discusses how Roche is:
Leveraging historical amendment data to enable study teams to understand why protocols are being amendedUtilizing a visual data science platform to generate insights from data to make better data-driven decisionsApplying retrospective learning into current protocols to curb the need for amendmentsBuilding in business value
For more information, go to DPHARMconference.com.

PharmaTalkRadio

PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.

Where can you listen?

Episodes